Thursday, August 09, 2018 1:49:05 PM
Feel free to look at the USMJ unaudited financials, last page, for this confirmation by USMJ that it is not fake news.
I'll provide and excerpt to help:
Series D Preferred Stock
On September 18, 2013, the Company filed a certificate of designation of Series
D Preferred Stock and the Company issued 100,000 shares of Series D preferred
stock to the former shareholders of Algae (See Note 1). Pursuant to the certificate
of designation:
• 100,000 shares were designated as Series D Preferred Stock.
• Holders of the Series D Preferred Stock will be entitled to receive $1.00 per
share of Series D Preferred Stock, prior to any distribution to holders of
common stock, in the event of any liquidation, dissolution or winding up of
the Company.
• Holders of Series D Preferred Stock will be entitled to receive dividends in
the amount of 51% of net income, payable quarterly.
• Holders of Series D Preferred Stock will own 51% of the voting power of
the shareholders of the Company.
The Company may not redeem shares of Series D Preferred Stock without the
written consent of the holders thereof.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM